Hepatitis

Hepatitis refers to inflammation of the liver and may be caused by viral infections, certain medicines, alcohol and other medical conditions. Viral hepatitis can vary in severity and duration, ranging from acute illness to chronic infection.

Hepatitis viruses have different transmission routes. Hepatitis A and E are commonly transmitted through contaminated food or water, while hepatitis B, C and D are associated with blood or other relevant bodily-fluid exposures. Appropriate testing is essential to identify the cause and determine the necessary treatment.

The supplied source describes an Ayurvedic treatment approach for different liver-related conditions and emphasizes monitoring liver function. Treatment must be tailored to the diagnosis, severity of illness and individual medical needs.

Monitoring and Evaluation

Bilirubin Levels

The supplied source recommends checking bilirubin every three days during the acute phase of hepatitis, together with SGOT (AST) and SGPT (ALT), to monitor disease progression and treatment response.

The source also recommends checking liver function tests (LFTs) every five days in cases where bilirubin exceeds 10 mg%.

The frequency of laboratory testing should be determined by the treating clinician according to the patient’s condition and the severity of liver injury. These schedules are source-stated recommendations, not universal monitoring guidelines.

Treatment Approach

The supplied source describes an Ayurvedic approach focused on liver health, symptom management, medication and lifestyle measures.

Management of hepatitis depends on its cause. Some viral infections resolve with supportive care, while others may require specific antiviral treatment and long-term monitoring. Ayurvedic products should not replace evidence-based medical care for viral hepatitis or significant liver disease.

Acute Hepatitis A and B

Bilirubin up to 5 mg%

Product listed in the source: Liv Care Plus Tablets.

• Source-stated dosage: 2 tablets every 3 hours for 10 days after food, described as six doses per day.

Bilirubin between 5 and 10 mg%

Product listed in the source: Liv Care Plus Tablets.

• Source-stated dosage: 3 tablets every 3 hours for 10–15 days.

Bilirubin of 10 mg% and above

Product listed in the source: Liv Care Plus Tablets.

• Source-stated dosage: 3 tablets every 2 hours for a minimum of 30 days or until LFT values normalize.
• The source recommends adequate water intake and consumption of natural fruits.
• The source emphasizes close observation when bilirubin exceeds 10 mg% and recommends LFT monitoring every five days.

These product schedules are reproduced from the supplied source and are not prescribing instructions. High bilirubin levels may indicate serious liver disease and require prompt medical assessment. Do not use these schedules to delay or replace hospital-based care.

Chronic Active Hepatitis

The supplied source describes chronic active hepatitis as hepatomegaly with elevated SGOT and SGPT for more than three months.

• Product listed: Liv Care Plus Tablets.
• Source-stated dosage: 2-2-2 after food for a minimum of six months or until LFT values normalize.

Persistent liver enzyme abnormalities require investigation to identify the underlying cause. Treatment and follow-up should be guided by a qualified medical specialist.

Gilbert’s Syndrome

The supplied source includes Gilbert’s syndrome under persistent hyperbilirubinemia.

• Product listed: Liv Care Plus Tablets.
• Source-stated dosage: 2-2-2 for 30 days, with repeat courses as needed.

Gilbert’s syndrome is a distinct condition and should not be confused with viral hepatitis or other causes of liver injury. Confirm the diagnosis and discuss treatment decisions with a qualified healthcare professional.

Non-Alcoholic Fatty Liver Disease (NAFLD/NASH)

• Product listed: Liv Care Plus Tablets.
• Source-stated dosage: 2-2-2 for 6 months to 1 year.
• The source recommends body-weight reduction as part of the management approach.

Fatty liver management should be individualized and may include sustainable dietary changes, physical activity and weight management where appropriate. Medication decisions depend on the individual’s diagnosis and overall health.

Chronic Liver Disease and Cirrhosis

The supplied source lists the following product for chronic liver disease described as cirrhosis with elevated SGOT and SGPT.

• Product listed: ZingiVir H Tablets.
• Source-stated dosage: 2-0-2 for 4–6 months.

Cirrhosis requires specialist assessment and ongoing monitoring. The safety of any herbal or Ayurvedic formulation should be reviewed by the treating clinician because some products may cause liver injury or interact with prescribed medicines.

Dietary Recommendations

The supplied source recommends easily digestible foods, a low-fat diet and carbohydrate-rich foods across the conditions described.

• Follow a balanced diet suited to the diagnosed liver condition and individual nutritional needs.
• Maintain adequate hydration unless fluid restriction has been advised.
• Seek individualized dietary guidance if cirrhosis or another advanced liver condition is present.